期刊
CURRENT BIOLOGY
卷 22, 期 17, 页码 R762-R771出版社
CELL PRESS
DOI: 10.1016/j.cub.2012.06.065
关键词
-
资金
- US National Institutes of Health [R01 GM079843-01, P01 CA91955, RO1 CA149566, RO1 CA140657]
- ARRA PDS [35063]
- European Commission [FP7231807]
- American Cancer Society [117209-RSG-09-163-01-CNE]
- Addario Lung Cancer Medical Institute
Cancer initiation, progression, and the emergence of therapeutic resistance are evolutionary phenomena of clonal somatic cell populations. Studies in microbial experimental evolution and the theoretical work inspired by such studies are yielding deep insights into the evolutionary dynamics of clonal populations, yet there has been little explicit consideration of the relevance of this rapidly growing field to cancer biology. Here, we examine how the understanding of mutation, selection, and spatial structure in clonal populations that is emerging from experimental evolution may be applicable to cancer. Along the way, we discuss some significant ways in which cancer differs from the model systems used in experimental evolution. Despite these differences, we argue that enhanced prediction and control of cancer may be possible using ideas developed in the context of experimental evolution, and we point out some prospects for future research at the interface between these traditionally separate areas.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据